A study to evaluate RINTEGA administered after surgery but prior to and concurrently with chemoradiation in newly diagnosed glioblastoma patients.
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2016
At a glance
- Drugs Rindopepimut (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 01 Mar 2016 New trial record
- 25 Feb 2016 According to Celldex Therapeutics Inc media release, the company expects to initiate this trial in the second half of 2016.